1. Resistin Induces Cardiomyocyte Hypertrophy in H9c2 Embryonic Rat Myocardial Cells via Inhibition of MiR-489-3p
   Pengjie Yang et al, 2023, Trends in Medical Research CrossRef
2. Omentin inhibits the resistin‑induced hypertrophy of H9c2 cardiomyoblasts by inhibiting the TLR4/MyD88/NF‑κB signaling pathway
   Xiaoliang Yan et al, 2022, Experimental and Therapeutic Medicine CrossRef
3. Diabetes and cardiovascular disease: inter-relation of risk factors and treatment
   Aman Sharma et al, 2020, Future Journal of Pharmaceutical Sciences CrossRef
4. Apelin/ELABELA-APJ system in cardiac hypertrophy: Regulatory mechanisms and therapeutic potential
   Bo Pang et al, 2023, European Journal of Pharmacology CrossRef
5. Resistin as a predictor of cardiovascular hospital admissions and renal deterioration in diabetic patients with chronic kidney disease
   Bruno Bonito et al, 2019, Journal of Diabetes and its Complications CrossRef
6. Overview of the Composition of Whole Grains’ Phenolic Acids and Dietary Fibre and Their Effect on Chronic Non-Communicable Diseases
   Jabir Khan et al, 2022, International Journal of Environmental Research and Public Health CrossRef
7. Impact of inflammation and anti-inflammatory modalities on diabetic cardiomyopathy healing: From fundamental research to therapy
   Xiao-Jiao Zhang et al, 2023, International Immunopharmacology CrossRef
8. A review of fibroblast growth factor 21 in diabetic cardiomyopathy
   Xiang Zhang et al, 2019, Heart Failure Reviews CrossRef
9. Apelinergic System Structure and Function
   Kyungsoo Shin et al, 2017, Comprehensive Physiology CrossRef